Schedule 13G ownership disclosure

Day One Biopharmaceuticals Inc

Security class unavailable · CUSIP: 23954D109

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,008,534
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-23-002065
Form type
SC 13G/A
Filer
Atlas Venture Fund XI, L.P.
CIK
CIK 1708269
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub